Annexon, Inc. ANNX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

58/100

3/6 Pass

SharesGrow Intrinsic Value

Il y a eu 50 transactions d'initiés récentes enregistrées pour Annexon, Inc. (ANNX), dont 33 achats et 17 ventes. Le total des achats d'initiés s'élève à $22.84M et le total des ventes d'initiés à $401.75K.

Les initiés notables ayant une activité récente comprennent Carson William H., Lew Jennifer, Dananberg Jamie. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — ANNX

Date	Nom	Rôle	Type de Transaction	Actions	Prix Moyen	Valeur	Actions détenues
2026-03-10	Carson William H.	Director	Achat Informatif	8,000	$5.67	$45.36K	62,405
2026-03-02	Lew Jennifer	EVP & Chief Financial Officer	Vente Informative	5,565	$5.42	$30.16K	170,700
2026-03-02	Dananberg Jamie	Chief Medical Officer	Vente Informative	5,820	$5.43	$31.6K	123,582
2026-03-02	Overdorf Michael	EVP & Chief Business Officer	Vente Informative	4,339	$5.42	$23.52K	182,625
2026-03-02	Yednock Ted	EVP & Chief Innovation Officer	Vente Informative	5,566	$5.42	$30.17K	154,161
2026-03-02	Artis Dean Richard	EVP & Chief Scientific Officer	Vente Informative	5,894	$5.43	$32K	180,093
2026-02-19	Lew Jennifer	EVP & Chief Financial Officer	Attribution de RSU	62,500	-	-	176,265
2026-02-19	Dananberg Jamie	Chief Medical Officer	Attribution de RSU	56,250	-	-	129,402
2026-02-19	Love Douglas	President and CEO	Attribution de RSU	1,250,000	$5.10	$6.38M	1,250,000
2026-02-19	Overdorf Michael	EVP & Chief Business Officer	Attribution de RSU	62,500	-	-	186,964
2026-02-19	Yednock Ted	EVP & Chief Innovation Officer	Attribution de RSU	62,500	-	-	159,727
2026-02-19	Artis Dean Richard	EVP & Chief Scientific Officer	Attribution de RSU	62,500	-	-	185,987
2026-02-18	Lew Jennifer	EVP & Chief Financial Officer	Vente Informative	7,851	$5.11	$40.12K	113,765
2026-02-18	Dananberg Jamie	Chief Medical Officer	Vente Informative	5,290	$5.10	$26.98K	73,152
2026-02-18	Overdorf Michael	EVP & Chief Business Officer	Vente Informative	6,225	$5.10	$31.75K	124,464
2026-02-18	Yednock Ted	EVP & Chief Innovation Officer	Vente Informative	7,857	$5.11	$40.15K	97,227
2026-02-18	Artis Dean Richard	EVP & Chief Scientific Officer	Vente Informative	5,290	$5.10	$26.98K	123,487
2025-12-30	Carson William H.	Director	Achat Informatif	4,115	$5.02	$20.66K	54,405
2025-12-01	Choi Jung	Director	Achat Informatif	33,000	$4.19	$138.27K	33,000
2025-12-01	Carson William H.	Director	Achat Informatif	4,115	$4.47	$18.39K	50,290
2025-11-21	Satter Muneer A	Director	Achat Informatif	422,613	$4.28	$1.81M	9,728,637
2025-11-20	Satter Muneer A	Director	Achat Informatif	400,000	$4.48	$1.79M	9,306,024
2025-11-19	Satter Muneer A	Director	Achat Informatif	500,000	$3.94	$1.97M	8,906,024
2025-11-18	Satter Muneer A	Director	Achat Informatif	500,000	$3.18	$1.59M	8,406,024
2025-11-17	Satter Muneer A	Director	Achat Informatif	500,000	$2.99	$1.5M	7,906,024
2025-10-30	Carson William H.	Director	Achat Informatif	4,115	$3.17	$13.04K	46,175
2025-09-30	Carson William H.	Director	Achat Informatif	4,115	$3.05	$12.55K	42,060
2025-09-02	Carson William H.	Director	Achat Informatif	4,115	$2.09	$8.6K	37,945
2025-07-30	Carson William H.	Director	Achat Informatif	4,115	$2.43	$10K	33,830
2025-07-14	Lew Jennifer	EVP & Chief Financial Officer	Vente Informative	1,117	$2.58	$2.88K	121,616
2025-07-14	Overdorf Michael	EVP & Chief Business Officer	Vente Informative	853	$2.61	$2.23K	130,689
2025-07-14	Yednock Ted	EVP & Chief Innovation Officer	Vente Informative	1,116	$2.58	$2.88K	105,084
2025-06-30	Carson William H.	Director	Achat Informatif	4,115	$2.46	$10.12K	29,715
2025-06-05	Wiggans Thomas G	Director	Attribution de RSU	55,000	$2.55	$140.25K	55,000
2025-06-05	Satter Muneer A	10 Percent Owner	Attribution de RSU	55,000	$2.55	$140.25K	55,000
2025-06-05	Jones William A Jr	Director	Attribution de RSU	55,000	$2.55	$140.25K	55,000
2025-06-05	Waddill William D.	Director	Attribution de RSU	55,000	$2.55	$140.25K	55,000
2025-06-05	Choi Jung	Director	Attribution de RSU	55,000	$2.55	$140.25K	55,000
2025-06-05	Carson William H.	Director	Attribution de RSU	55,000	$2.55	$140.25K	55,000
2025-06-05	Cockroft Bettina M.	Director	Attribution de RSU	55,000	$2.55	$140.25K	55,000
2025-02-27	Lew Jennifer	EVP & Chief Financial Officer	Attribution de RSU	272,575	$2.50	$681.44K	272,575
2025-02-27	Dananberg Jamie	Chief Medical Officer	Attribution de RSU	228,225	$2.50	$570.56K	228,225
2025-02-27	Love Douglas	President and CEO	Attribution de RSU	1,300,000	$2.50	$3.25M	1,300,000
2025-02-27	Overdorf Michael	EVP & Chief Business Officer	Attribution de RSU	272,575	$2.50	$681.44K	272,575
2025-02-27	Yednock Ted	EVP & Chief Innovation Officer	Attribution de RSU	272,575	$2.50	$681.44K	272,575
2025-02-27	Artis Dean Richard	EVP & Chief Scientific Officer	Attribution de RSU	272,575	$2.50	$681.44K	272,575
2025-02-18	Lew Jennifer	EVP & Chief Financial Officer	Vente Informative	6,912	$2.92	$20.18K	77,770
2025-02-18	Dananberg Jamie	Chief Medical Officer	Vente Informative	5,521	$2.96	$16.34K	33,479
2025-02-18	Overdorf Michael	EVP & Chief Business Officer	Vente Informative	6,618	$2.95	$19.52K	86,579
2025-02-18	Yednock Ted	EVP & Chief Innovation Officer	Vente Informative	8,345	$2.91	$24.28K	61,237

■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration